AVITA Medical, Inc.

AVITA Medical, Inc.

RCELยทNASDAQ

$4.16

-5.0%
HealthcareMedical - Devices

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

At a Glance

Live Snapshot
Market Cap$103.35M
EPS-1.7400
P/E Ratio-2.39
Earnings Date08/06/2026

No Dividend Yield Data

RCEL has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

RCEL has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

RCEL has not reported any net dividends paid values in the available annual periods.

AVITA Medical, Inc.

AVITA Medical, Inc. Dividend History

RCEL ยท NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

RCEL Dividend Payment History

RCEL ยท NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
rcel

AVITA Medical, Inc. Payout Ratio Analysis

RCEL ยท NASDAQ
Dividends Paid
0.00
2025
Net Income
-48.59M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.